141 related articles for article (PubMed ID: 28314511)
1. Novel platinum(IV) complexes conjugated with a wogonin derivative as multi-targeted anticancer agents.
Qin X; Xu G; Chen F; Fang L; Gou S
Bioorg Med Chem; 2017 Apr; 25(8):2507-2517. PubMed ID: 28314511
[TBL] [Abstract][Full Text] [Related]
2. Reversal of cisplatin resistance in human gastric cancer cells by a wogonin-conjugated Pt(IV) prodrug via attenuating Casein Kinase 2-mediated Nuclear Factor-κB pathways.
Chen F; Qin X; Xu G; Gou S; Jin X
Biochem Pharmacol; 2017 Jul; 135():50-68. PubMed ID: 28288821
[TBL] [Abstract][Full Text] [Related]
3. Disruption of SSBs repair to combat platinum resistance via the JWA-targeted Pt(IV) prodrug conjugated with a wogonin derivative.
Wang X; Li L; Pei S; Zhu Q; Chen F
Pharmazie; 2020 Mar; 75(2):94-101. PubMed ID: 32213241
[TBL] [Abstract][Full Text] [Related]
4. Research progress in modern structure of platinum complexes.
Bai L; Gao C; Liu Q; Yu C; Zhang Z; Cai L; Yang B; Qian Y; Yang J; Liao X
Eur J Med Chem; 2017 Nov; 140():349-382. PubMed ID: 28985575
[TBL] [Abstract][Full Text] [Related]
5. Characterization of chemosensitivity and resistance of human cancer cell lines to platinum(II) versus platinum(IV) anticancer agents.
Hamberger J; Liebeke M; Kaiser M; Bracht K; Olszewski U; Zeillinger R; Hamilton G; Braun D; Bednarski PJ
Anticancer Drugs; 2009 Aug; 20(7):559-72. PubMed ID: 19491657
[TBL] [Abstract][Full Text] [Related]
6. Platinum(IV)-nitroxyl complexes as possible candidates to circumvent cisplatin resistance in RT112 bladder cancer cells.
Cetraz M; Sen V; Schoch S; Streule K; Golubev V; Hartwig A; Köberle B
Arch Toxicol; 2017 Feb; 91(2):785-797. PubMed ID: 27307157
[TBL] [Abstract][Full Text] [Related]
7. Effective platinum(IV) prodrugs conjugated with lonidamine as a functional group working on the mitochondria.
Chen H; Chen F; Hu W; Gou S
J Inorg Biochem; 2018 Mar; 180():119-128. PubMed ID: 29253663
[TBL] [Abstract][Full Text] [Related]
8. Discovery and synthesis of novel Wogonin derivatives with potent antitumor activity in vitro.
Wang J; Ge R; Qiu X; Xu X; Wei L; Li Z; Bian J
Eur J Med Chem; 2017 Nov; 140():421-434. PubMed ID: 28987604
[TBL] [Abstract][Full Text] [Related]
9. Wogonin potentiates cisplatin-induced cancer cell apoptosis through accumulation of intracellular reactive oxygen species.
He F; Wang Q; Zheng XL; Yan JQ; Yang L; Sun H; Hu LN; Lin Y; Wang X
Oncol Rep; 2012 Aug; 28(2):601-5. PubMed ID: 22665077
[TBL] [Abstract][Full Text] [Related]
10. Targeting ROS-AMPK pathway by multiaction Platinum(IV) prodrugs containing hypolipidemic drug bezafibrate.
Qiao X; Gao YY; Zheng LX; Ding XJ; Xu LW; Hu JJ; Gao WZ; Xu JY
Eur J Med Chem; 2021 Nov; 223():113730. PubMed ID: 34388483
[TBL] [Abstract][Full Text] [Related]
11. A Pt(IV)-based mononitro-naphthalimide conjugate with minimized side-effects targeting DNA damage response via a dual-DNA-damage approach to overcome cisplatin resistance.
Li Y; Yue K; Li L; Niu J; Liu H; Ma J; Xie S
Bioorg Chem; 2020 Aug; 101():104011. PubMed ID: 32599363
[TBL] [Abstract][Full Text] [Related]
12. The influence of tumour microenvironmental factors on the efficacy of cisplatin and novel platinum(IV) complexes.
Mellor HR; Snelling S; Hall MD; Modok S; Jaffar M; Hambley TW; Callaghan R
Biochem Pharmacol; 2005 Oct; 70(8):1137-46. PubMed ID: 16139250
[TBL] [Abstract][Full Text] [Related]
13. Multi-action Pt(IV) anticancer agents; do we understand how they work?
Gibson D
J Inorg Biochem; 2019 Feb; 191():77-84. PubMed ID: 30471522
[TBL] [Abstract][Full Text] [Related]
14. V8, a newly synthetic flavonoid, induces apoptosis through ROS-mediated ER stress pathway in hepatocellular carcinoma.
Zhang Y; Zhao L; Li X; Wang Y; Yao J; Wang H; Li F; Li Z; Guo Q
Arch Toxicol; 2014 Jan; 88(1):97-107. PubMed ID: 23835921
[TBL] [Abstract][Full Text] [Related]
15. Beyond mere DNA damage: Recent progress in platinum(IV) anticancer complexes containing multi-functional axial ligands.
Deng Z; Zhu G
Curr Opin Chem Biol; 2023 Jun; 74():102303. PubMed ID: 37075513
[TBL] [Abstract][Full Text] [Related]
16. Platinum(IV) complexes conjugated with phenstatin analogue as inhibitors of microtubule polymerization and reverser of multidrug resistance.
Huang X; Huang R; Gou S; Wang Z; Liao Z; Wang H
Bioorg Med Chem; 2017 Sep; 25(17):4686-4700. PubMed ID: 28728896
[TBL] [Abstract][Full Text] [Related]
17. Synthesis, evaluation and quantitative structure-activity relationship (QSAR) analysis of Wogonin derivatives as cytotoxic agents.
Bian J; Li T; Weng T; Wang J; Chen Y; Li Z
Bioorg Med Chem Lett; 2017 Feb; 27(4):1012-1016. PubMed ID: 28117202
[TBL] [Abstract][Full Text] [Related]
18. Antitumor platinum(IV) derivatives of oxaliplatin with axial valproato ligands.
Novohradsky V; Zerzankova L; Stepankova J; Vrana O; Raveendran R; Gibson D; Kasparkova J; Brabec V
J Inorg Biochem; 2014 Nov; 140():72-9. PubMed ID: 25063910
[TBL] [Abstract][Full Text] [Related]
19. Cellular accumulation and DNA platination of two new platinum(II) anticancer compounds based on anthracene derivatives as carrier ligands.
Marqués-Gallego P; Kalayda GV; Jaehde U; Dulk Hd; Brouwer J; Reedijk J
J Inorg Biochem; 2009 May; 103(5):791-6. PubMed ID: 19303143
[TBL] [Abstract][Full Text] [Related]
20. Biological activity of a series of cisplatin-based aliphatic bis(carboxylato) Pt(IV) prodrugs: how long the organic chain should be?
Zanellato I; Bonarrigo I; Colangelo D; Gabano E; Ravera M; Alessio M; Osella D
J Inorg Biochem; 2014 Nov; 140():219-27. PubMed ID: 25171667
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
